Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prenatal treatment of congenital cytomegalovirus infection with letermovir versus valaciclovir
2020-002924-35Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in congenital cytomegalovirus infection (cCMV) comparing Letermovir (Prevymis) arm with Valaciclovir arm (2 arms). Started Oct 2020; status: active.
02
Drugs
letermovirvalaciclovir
03
Conditions
congenital cytomegalovirus infection (cCMV)
Beyond the preview
Go deeper on 2020-002924-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002924-35.